Activating two somatostatin receptors enhances amyloid beta breakdown and improves memory in models of Alzheimer’s disease.

Grafton Therapeutics Sarl has identified halogenated somatostatin analogues acting as somatostatin SST2 receptor and/or SST5 receptor agonists reported to be useful for the treatment of cancer.

Researchers at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two receptors in the brain that control the breakdown of amyloid beta, a substance that ...

Somatostatin receptors (SSTRs) constitute a crucial family of G protein-coupled receptors (GPCRs) that play pivotal roles in regulating hormone secretion and inhibiting tumor growth. Among five ...

Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.

If you or a loved one has gastroenteropancreatic neuroendocrine tumors (GEP-NETs), you may be interested in learning about treatment options. One medicine you might hear about is Lutathera (lutetium ...

One of the world's most venomous creatures could be a new source of inspiration for drugs to treat diseases affecting hundreds of millions of people, a new study suggests. Led by researchers from the ...